BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Lacticaseibacillus casei {L. casei} - Alloprevotella |
📓
Lactobacillus casei combined with Lactobacillus reuteri alleviate pancreatic cancer by inhibiting TLR4 to promote macrophage M1 polarization and regulate gut microbial homeostasis. BMC cancer (BMC Cancer ) Vol: 23 Issue 1 Pages: 1044 Pub: 2023 Oct 30 Epub: 2023 Oct 30 Authors Zhu Z , Yi B , Tang Z , Chen X , Li M , Xu T , Zhao Z , Tang C , Html Article Publication |
| Lacticaseibacillus casei {L. casei} - Alloprevotella |
📓
Lactobacillus casei LC89 exerts antidiabetic effects through regulating hepatic glucagon response and gut microbiota in type 2 diabetic mice. Food & function (Food Funct ) Vol: 12 Issue 18 Pages: 8288-8299 Pub: 2021 Sep 20 Epub: 2021 Sep 20 Authors Zhang Y , Wu T , Li W , Zhao Y , Long H , Liu R , Sui W , Zhang M , Publication |
| Lacticaseibacillus casei {L. casei} - Alloprevotella |
👶
454 pyrosequencing reveals changes in the faecal microbiota of adults consuming Lactobacillus casei Zhang. FEMS microbiology ecology (FEMS Microbiol Ecol ) Vol: 88 Issue 3 Pages: 612-22 Pub: 2014 Jun Epub: Authors Zhang J , Wang L , Guo Z , Sun Z , Gesudu Q , Kwok L , Menghebilige , Zhang H , Publication Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
